Centiva Capital, LP Kala Pharmaceuticals, Inc. Transaction History

Centiva Capital, LP

  • $3.72 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$2.62 - $5.43 $152,790 - $316,661
-58,317 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$5.06 - $8.15 $295,084 - $475,283
58,317 New
58,317 $309,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $9.82M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email